欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	NL/H/0577/004
药品名称	Lopid 450 mg tablets
活性成分	gemfibrozil 450.0 mg
剂型	Tablet
上市许可持有人	Pfizer bv Rivium Westlaan 142 2909 LD Capelle a/d IJssel The Netherlands
参考成员国 - 产品名称	Netherlands (NL)
互认成员国 - 产品名称	Denmark (DK) France (FR) Austria (AT) Gevilon 450 mg - Filmtabletten
许可日期	2008/04/05
最近更新日期	2024/02/01
药物ATC编码	C10AB04 gemfibrozil
申请类型	TypeLevel1：[not specified] TypeLevel2：[not specified] TypeLevel3：[not specified] TypeLevel4：[not specified] TypeLevel5：[not specified]
附件文件下载	Final PL \| common_pil_Tablets_cleanDate of last change:2023/04/13 Final SPC \| common-spcDate of last change:2020/11/18 Final Product Information \| common-combined-lopidDate of last change:2019/12/02 Final Labelling \| 1-3-1-Lopid (gemfibrozil) 900 mg tablets carton cleanDate of last change:2014/01/21 Final Labelling \| 1-3-1-Lopid (gemfibrozil) 600 mg tablets carton cleanDate of last change:2014/01/21 Final Labelling \| 1-3-1-Lopid (gemfibrozil) 450 mg tablets carton cleanDate of last change:2014/01/21 Final Labelling \| 1-3-1-Lopid (gemfibrozil) 300 mg capsules carton cleanDate of last change:2014/01/21 Final Labelling \| common-interpack-900-mgtabslabelblistercleanDate of last change:2014/01/21 Final Labelling \| common-interpack-600-mgtabslabelblistercleanDate of last change:2014/01/21 Final Labelling \| common-interpack-450-mgtabslabelblistercleanDate of last change:2014/01/21 Final Labelling \| common-interpack-300-mgcapslabelblistercleanDate of last change:2014/01/21
市场状态	Positive